Skip to main content
SpringerLink
Log in

New products will drive growth of almost $US5 billion in the coronary heart disease (CHD) market, despite patent expirations affecting leading therapies

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Decision Resources.Despite Patent Expiries of Leading Therapies, New Product Launches Will Drive a $4.6 Billion Increase in the Coronary Heart Disease Market. Media Release: 24 Mar 2009. Available from: URL: http://www.decisionresources.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

New products will drive growth of almost $US5 billion in the coronary heart disease (CHD) market, despite patent expirations affecting leading therapies. Pharmacoecon. Outcomes News 575, 10 (2009). https://doi.org/10.2165/00151234-200905750-00018

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905750-00018

Keywords

Search

Navigation